Literature DB >> 9798096

Avirulence and immunogenicity in mice of a bovine mastitis Staphylococcus aureus mutant.

C Bogni1, M Segura, J Giraudo, A Giraudo, A Calzolari, R Nagel.   

Abstract

An avirulent mutant, designated RC122, was derived from Staphylococcus aureus bovine mastitis strain RC108 after N-methyl-N'-nitro-N-nitrosoguanidine mutagenesis. Mutant RC122, which was isolated on the basis of reduced colony size, showed diminished virulence in mice (LD50 of RC122: 3.1 x 10(10) cfu vs LD50 of RC108: 2.3 x 10(7) cfu). Mutant RC122 grew more slowly than its parental strain and showed decreased production of several exoproteins, such as alpha- and beta-hemolysin, DNAse and coagulase. The production of its capsule was induced only under in vivo growth conditions. Clearance studies performed in the mouse kidney revealed that the kinetics of disappearance of the mutant was similar to that of its parental strain. Protection experiments carried out by intraperitoneal administration in mice showed that mutant RC122 conferred a good degree of protection from challenge with homologous and heterologous strains.

Entities:  

Mesh:

Year:  1998        PMID: 9798096      PMCID: PMC1189497     

Source DB:  PubMed          Journal:  Can J Vet Res        ISSN: 0830-9000            Impact factor:   1.310


  25 in total

1.  Staphylococcal mastitis vaccine.

Authors:  D L Watson
Journal:  Vaccine       Date:  1992       Impact factor: 3.641

2.  [Comparison of detection methods for the Staphylococcus aureus capsule].

Authors:  L Odierno; A Zandarín; M Ferrari; A Rampone; J Giraudo; A Calzolari
Journal:  Rev Latinoam Microbiol       Date:  1995 Jul-Sep

3.  Phenotypic characterization and virulence of a sae- agr- mutant of Staphylococcus aureus.

Authors:  A T Giraudo; H Rampone; A Calzolari; R Nagel
Journal:  Can J Microbiol       Date:  1996-02       Impact factor: 2.419

4.  In vivo expression of exoprotein synthesis with a Sae mutant of Staphylococcus aureus.

Authors:  H Rampone; G L Martínez; A T Giraudo; A Calzolari; R Nagel
Journal:  Can J Vet Res       Date:  1996-07       Impact factor: 1.310

5.  Genetic and molecular analyses of the gene encoding staphylococcal enterotoxin D.

Authors:  K W Bayles; J J Iandolo
Journal:  J Bacteriol       Date:  1989-09       Impact factor: 3.490

6.  Field trials of a vaccine against bovine mastitis. 2. Evaluation in two commercial dairy herds.

Authors:  A Calzolari; J A Giraudo; H Rampone; L Odierno; A T Giraudo; C Frigerio; S Bettera; C Raspanti; J Hernández; M Wehbe; M Mattea; M Ferrari; A Larriestra; R Nagel
Journal:  J Dairy Sci       Date:  1997-05       Impact factor: 4.034

7.  Enhanced virulence of Staphylococcus aureus from bovine mastitis induced by growth in milk whey.

Authors:  W Mamo; M Lindahl; P Jonsson
Journal:  Vet Microbiol       Date:  1991-05       Impact factor: 3.293

8.  Virulence of protein A-deficient and alpha-toxin-deficient mutants of Staphylococcus aureus isolated by allele replacement.

Authors:  A H Patel; P Nowlan; E D Weavers; T Foster
Journal:  Infect Immun       Date:  1987-12       Impact factor: 3.441

9.  The accessory gene regulator (agr) controls Staphylococcus aureus virulence in a murine arthritis model.

Authors:  A Abdelnour; S Arvidson; T Bremell; C Rydén; A Tarkowski
Journal:  Infect Immun       Date:  1993-09       Impact factor: 3.441

10.  Immunisation against experimental staphylococcal mastitis in sheep - effect of challenge with a heterologous strain of Staphylococcus aureus.

Authors:  D L Watson; J W Kennedy
Journal:  Aust Vet J       Date:  1981-07       Impact factor: 1.281

View more
  2 in total

1.  Bovine and rabbit models for the study of a Staphylococcus aureus avirulent mutant strain, RC122.

Authors:  Elina Reinoso; Gabriel Magnano; Jose Giraudo; Aldo Calzolari; Cristina Bogni
Journal:  Can J Vet Res       Date:  2002-10       Impact factor: 1.310

2.  Mastitis Pathogens with High Virulence in a Mouse Model Produce a Distinct Cytokine Profile In Vivo.

Authors:  Carl-Fredrik Johnzon; Karin Artursson; Robert Söderlund; Bengt Guss; Elin Rönnberg; Gunnar Pejler
Journal:  Front Immunol       Date:  2016-09-22       Impact factor: 7.561

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.